Ozempic Increase Is An Opportunity For Health Insurers
The progress is basically because of continued utilization of drugs and higher prices for specialty medicine but will be partially offset by reimbursement stress, lowered profit margins, and the expansion of specialty generics and biosimilars. In July 2022, we estimated that 2022 HST profit pools can be $53.7 billion. We have revised our estimate to $49 billion due to wage inflation and the drag of mounted know-how funding that has not achieved its full advantages yet. For additional info on the government phase, see “Medicare Payment Advisory Commission public assembly,” Medicare Payment Advisory Commission, December eight, 2022.
New Remedy That…